Financial Performance - The company's revenue for Q1 2024 was ¥174,756,744.24, a decrease of 44.80% compared to ¥316,598,101.62 in the same period last year[5] - The net profit attributable to shareholders was a loss of ¥32,254,599.78, a significant decline from a profit of ¥156,915.24 in the previous year, representing a decrease of 20,655.43%[5] - Total operating revenue for Q1 2024 was ¥174,756,744.24, a decrease of 44.7% compared to ¥316,598,101.62 in Q1 2023[26] - Net loss for Q1 2024 was ¥32,952,304.31, compared to a net profit of ¥156,915.24 in Q1 2023, indicating a significant decline in profitability[27] - The total comprehensive income attributable to the parent company for Q1 2024 was -32,254,599.78 CNY, compared to 156,915.24 CNY in the previous period[28] Cash Flow - The net cash flow from operating activities was -¥35,573,279.63, an improvement of 38.34% compared to -¥57,690,291.53 in the same period last year[5] - Cash inflow from operating activities totaled 247,181,742.44 CNY, up from 155,831,823.87 CNY year-over-year[30] - Total cash outflow from operating activities was 282,755,022.07 CNY, compared to 213,522,115.40 CNY in the previous period[30] - The net cash flow from investing activities was -16,208,000.62 CNY, a decrease from a positive cash flow of 15,256,977.92 CNY in the previous period[30] - The net cash flow from financing activities was 20,555,116.18 CNY, a decrease from 66,324,759.97 CNY in the previous period[30] Assets and Liabilities - Total assets at the end of the reporting period were ¥1,650,829,463.30, down 3.11% from ¥1,703,876,246.13 at the end of the previous year[5] - Total liabilities decreased slightly to ¥883,105,039.87 in Q1 2024 from ¥892,130,907.58 in Q1 2023, a decline of 1.3%[24] - The company's cash and cash equivalents at the end of the reporting period amounted to 155,921,429.11 RMB, down from 171,754,915.51 RMB at the beginning of the period[21] - The company's total current assets amounted to ¥819,422,526.92, down from ¥850,879,943.46 in the previous year[23] Shareholder Information - The total number of common shareholders at the end of the reporting period is 12,710[12] - The company repurchased 1,000,700 shares, accounting for 0.87% of the total share capital, with a total transaction amount of 12,483,609 RMB[18] - The controlling shareholder proposed a share buyback to maintain company value and shareholder rights[17] - The company’s major shareholder, Zang Zhicheng, holds 31.81% of the shares, totaling 36,650,000 shares[12] - The company’s shareholding structure includes several significant shareholders, with the top ten holding a combined total of 52.64%[12] Expenses and Investments - Research and development expenses for Q1 2024 were ¥16,324,825.71, slightly down from ¥16,528,370.05 in Q1 2023, indicating a focus on maintaining R&D investment[27] - The company reported a significant increase in sales expenses to ¥9,733,736.78 in Q1 2024 from ¥8,575,596.08 in Q1 2023, reflecting a rise of 13.5%[27] - The company paid 43,321,045.96 CNY in employee compensation during Q1 2024, compared to 49,890,286.95 CNY in the previous period[30] Equity and Earnings - The equity attributable to shareholders decreased by 5.33% to ¥768,970,074.69 from ¥812,293,285.28 at the end of the previous year[5] - The company’s basic and diluted earnings per share were both -¥0.28, compared to ¥0.00 in the same period last year[5] - The company’s weighted average return on equity was -4.05%, a decrease of 4.07% from 0.02% in the previous year[5] - The company’s retained earnings showed a decline, with an accumulated deficit of ¥95,906,050.94 in Q1 2024 compared to ¥63,651,451.16 in Q1 2023[24] Inventory and Receivables - The company’s inventory increased to ¥233,155,873.73 in Q1 2024 from ¥212,233,444.30 in Q1 2023, an increase of 9.8%[23] - The company’s accounts receivable financing decreased by 75.89% to ¥13,896,055.39, primarily due to a reduction in bank acceptance bills[9] - The company’s accounts receivable notes stood at 15,617,752.00 RMB at the end of the reporting period, slightly up from 15,518,466.24 RMB at the beginning[21]
凯龙高科(300912) - 2024 Q1 - 季度财报